Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
Elizabeth M. Anderson, Scott E. Hensley(University of Pennsylvania), Ajinkya Pattekar(University of Pennsylvania), Philip Hicks(University of Pennsylvania), Eileen C. Goodwin(University of Pennsylvania), Claudia P. Arevalo(University of Pennsylvania), Anurag Verma(Teerthanker Mahaveer University), Jennifer E. Wu(Parker Institute for Cancer Immunotherapy), Christopher M. McAllister(University of Pennsylvania), Michael R. Betts(University of Pennsylvania), Nicholas Han(Translational Therapeutics (United States)), Holly Ramage(Thomas Jefferson University), Sigrid Gouma(University of Pennsylvania), Justin Kim(Translational Therapeutics (United States)), Divij Mathew(Parker Institute for Cancer Immunotherapy), Alex C. Huang(Translational Therapeutics (United States)), Marcus J. Bolton(University of Pennsylvania), Nuala J. Meyer(Translational Therapeutics (United States)), Cécile Alanio(Inserm), Sara Cherry(California University of Pennsylvania), Derek A. Oldridge(California University of Pennsylvania), Paul Bates(University of Pennsylvania), Laura A. Vella(Children's Hospital of Philadelphia), E. John Wherry(Parker Institute for Cancer Immunotherapy), Jeanette Dougherty(Translational Therapeutics (United States)), Daniel J. Rader(University of Pennsylvania), M. Betina Pampena(University of Pennsylvania), Allison R. Greenplate(California University of Pennsylvania), Oliva Kuthuru(Translational Therapeutics (United States)), Amy E. Baxter(Translational Therapeutics (United States)), Tomaz B. Manzoni(University of Pennsylvania), Leticia Kuri-Cervantes(University of Pennsylvania), Sokratis A. Apostolidis(University of Pennsylvania), Kurt D’Andrea(University of Pennsylvania), Oluwatosin Oniyide(University of Pennsylvania), Madison E. Weirick(University of Pennsylvania), Shannon Christensen(University of Pennsylvania), JoEllen Weaver(University of Pennsylvania)
Cited by 412
Related Papers
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
|Nature Genetics|2006|2.3k
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
|Nature|2010|1.8k
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
|New England Journal of Medicine|2016|1.5k